Unaudited Consolidated Financial Results for Quarter and Nine Months Ended 31st December, 2008

Particulars	Quarter Ended 31st December 2008	Quarter Ended 31st December 2007	Nine Months Ended 31st December 2008	Nine Months Ended 31st December 2007	Year ended 31st March 2008
	(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Audited)
a. Gross Sales / Income from Operation	20726.33	21623.92	65864.08	54977.47	77736.42
Less : Excise Duty	2549.52	2702.31	8209.42	6880.93	9612.33
Net Sales / Income from Operation	18176.81	18921.61	57654.66	48096.54	68124.09
b. Other Operating Income	2.42	0.51	2.62	1.11	-
Total Income (a+b)	18179.23	18922.12	57657.28	48097.65	68124.09
Expenditure
a. Increase / (Decrease) in stock in trade     and work in progress	(547.95)	(524.89)	(603.48)	(575.74)	(285.59)
b. Consumption of Raw Materials	12014.97	12755.53	37474.62	31704.58	44612.61
c. Employees Cost	651.23	461.72	1736.02	1193.84	1498.14
d. Depreciation	693.29	572.71	1933.92	1520.51	2091.61
e. Other Expenditure	2448.12	2211.53	7279.61	5631.86	7856.42
Total Expenditure	15259.66	15476.60	47820.69	39475.05	55773.19
Profit from Operations before Other Income, Interest & Exceptional Items (2-3)	2919.57	3445.52	9836.59	8622.60	12350.90
Other Income	-	-	-	-	29.96
Profit before Interest & Exceptional Items (4+5)	2919.57	3445.52	9836.59	8622.60	12380.86
Interest (Net)	689.21	489.64	1913.32	1371.76	1827.77
Profit after Interest but before Exceptional Items (6-7)	2230.36	2955.88	7923.27	7250.84	10553.09
Exceptional Items	-	-	-	-	-
Profit From Ordinary Activities Before Tax (8+9)	2230.36	2955.88	7923.27	7250.84	10553.09
Tax Expenses
a. Current	573.90	475.30	2108.60	1359.60	1968.40
b. Deffered	63.70	38.40	180.50	110.80	382.70
Net Profit (+) / Loss (-) from Ordinary Activities after tax (10-11)	1592.76	2442.18	5634.17	5780.44	8201.99
Minority Interests in Net Profit of Subsidiaries	142.89	301.12	617.20	560.32	834.89
Net Profit For the period (12-13)	1449.87	2141.06	5016.97	5220.12	7367.10
Extraordinary Item (Net of Tax Expenses Rs Nil)	-	-	-	1338.90	1338.90
Net Profit For the period after Extra ordinary Items (14+15)	1449.87	2141.06	5016.97	6559.02	8706.00
Paid -up equity share capital	2092.65	2092.65	2092.65	2092.65	2092.65
Reserve excluding Revaluation Reserves	-	-	-	-	37931.06
Earnings Per Share ( EPS )
a. Before Extraordinary items
Basic Diluted	0.69* 0.68*	10.60** 10.60**	2.40* 2.39*	25.80** 25.80**	36.50** 36.40**
b. After Extraordinary items
Basic Diluted	0.69* 0.68*	10.60** 10.60**	2.40* 2.39*	32.40** 32.40**	43.00** 42.90**
Public shareholding
a. Number of shares	78601000	7860100	78601000	7860100	7860100
b. Percentage of share Holding	37.56	37.56	37.56	37.56	37.56

Consolidated Segment Wise Revenue, Results And Capital Employed

Particulars	Quarter Ended 31st December 2008	Quarter Ended 31st December 2007	Nine Months Ended 31st December 2008	Nine Months Ended 31st December 2007	Year ended 31st March 2008
	(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Audited)
Segment Revenue
a. Polymer Products	14217.62	14933.30	45329.88	38470.60	54943.70
b. Composite Products	4299.41	3988.31	13554.80	9625.94	14261.37
Total	18517.03	18921.61	58884.68	48096.54	69205.07
Less : Inter Segment Revenue	(340.22)	-	(1230.02)	-	(1080.98)
Net Sales/Income from operations	18176.81	18921.61	57654.66	48096.54	68124.09
Segment Results
Profit before tax and interest from each segment
a. Polymer Products	1975.78	2235.87	6278.17	6002.35	8435.01
b. Composite Products	943.79	1209.65	3558.42	2620.24	3915.89
Total	2919.57	3445.52	9836.59	8622.59	12350.90
Less:
i) Interest	689.21	489.64	1913.32	1371.76	1827.77
ii) Other Un-allocable Income net off	-	-	-	-	29.96
Total Profit Before Tax	2230.36	2955.88	7923.27	7250.83	10553.09
Capital Employed a. Polymer Products b. Composite Products	56283.14 8594.94	43662.59 6528.69	56283.14 8594.94	43662.59 6528.69	51564.83 6325.60
Total	64878.08	50191.28	64878.08	50191.28	57890.43

Note

• The above Financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on January 31, 2009.Limited Review of the same has been carried out by the statutory auditors of the Company in terms of Clause 41 of the Listing agreement.
• The above results reflect the adjustment in the value of inventories, arising out of steep fall in the prices of raw materials (mainly Polymers and Lead) during the quarter, thereby adversely affecting the sales value and profitability. Meanwhile prices have started rising sharply, this should result in improved sales value and profitability hereafter.
• Effective Jan 09, Company has succesfully started its new project at Silvassa (U.T.) for High Pressure Pipes, which will start contributing from Q4 of the current financial year.
• Company's new project for" Prefab structures and Shelters" is progressing satisfactorily and is likely to commence production in Q1 FY '10 on schedule.
• NED's (Subsidiary) battery Expansion project at Panoli (Gujarat) is under final stage of completion and would commence commercial production in Q4 of the current financial year on schedule.
• Ministry of Health, Govt. of India has in Dec,08 made the use of 'Single use Syringes 'mandatory effective April' 09. Our healthcare segment would be one of the beneficiary of implementaion of this regulation.
• The standalone results are available at Company's website : www.timetechnoplast.com or www.bseindia.com or www.nseindia.com
• The Investor Correpsondence / complaints received and dispensed off during the quarter ended December 31, 2008 : Opening : Nil, Received :01 , Replied/Resolved : 01; Pending at the end of the quarter : Nil.
• Figures of previous periods have been regrouped / rearranged wherever considered necessary.

For And on Behalf of the Board